diagnostic

FDA Releases Draft Guidance and Announces Webinar on CLIA Waiver Applications

November 28, 2018

McDermott+Consulting

The U.S. Food and Drug Administration has updated and released two draft guidance documents (here and here) that aim to help manufacturers of in vitro diagnostic (IVD) devices apply for and receive Clinical Laboratory Improvement Amendments (CLIA) waivers.

Webinar Details:

Date: Wednesday, January 9, 2019
Time: 1:00 – 2:30 PM Eastern Time

You can access the webinar information here.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope